Companies · Other Health Care

New IVS Holdings, LLC

Avon · Other Health Care

Diligence memoA one-page analyst read on New IVS Holdings, LLC — recommendation, valuation, rhythm, risks.
$575K
Total raised · real
1
Rounds
Latest step-up
Top 77%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

New IVS Holdings, LLC looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 2.18× the median modeled value of Pre-Seed Other Health Care companies in 2019–2021 (295 peers) — value vs value, same stage and era.
Dormant
  • Last raise 6.8 yr ago; this sector typically re-raises about every 14 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

New IVS Holdings, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
6.8 yr record
Peak capital year was 2019 with $575K across 1 filings.
Market position
ahead of 24% of Other Health Care peers
Capital scale is ahead of 24% of Other Health Care peers; modeled value is above 46% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2019: $575K across 1 filings.
  • Largest single filing was $575K on 2019-10-01.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

New IVS Holdings, LLC is one of 5377 Other Health Care companies tracked from Avon. By capital raised it ranks in the long tail (ahead of 24% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
15
Investors (latest)
2019
Year incorporated
2019-10-01
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$5.0M$10M$15M$20MPre-Seed · 2019-10-01 Raised $575K (real) Modeled valuation $18M (est)$575K$18MPre-Seed2019

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$575K · 2019

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$17.7M
Base estimate est.
$360K
Conservative case
$200.9M
Upside case
$3.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
28%
Survival probability
11% low · 52% high
1.64×/yr
Annual markup
2.23×/yr upside case
6.0 yr
Elapsed time used
6.8 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
Avg between rounds
Capital velocity
6.8 yr
On record since
2019
First round
1
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.2× of median
This company$575K
Sector median$2.4M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 1.6× above median
This company$575K
Sector median$350K
Modeled value — vs sector median (estimate, all stages) 0.8× of median
This company$17.7M
Sector median$22.1M

Raised more than 24% of sector peers (real $). Modeled value above 46% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #46 of 295.

This companyCohort peer
$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Aetas Co LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)Hauppauge SC Holdings, LLC · Pre-Seed Raised $995K · modeled $30.6M (est)Gateway IV Lithotripsy, LLC · Pre-Seed Raised $988K · modeled $30.4M (est)Endoscopy Center of West Central Ohio, LLC · Pre-Seed Raised $964K · modeled $29.7M (est)Dalent LLC · Pre-Seed Raised $1.9M · modeled $29.2M (est)FK Investor LLC · Pre-Seed Raised $940K · modeled $29.0M (est)Lynx Dx, Inc. · Pre-Seed Raised $925K · modeled $28.5M (est)Center at Arrowhead, LLC · Pre-Seed Raised $918K · modeled $28.3M (est)MedTek Valencia eCoin, LLC · Pre-Seed Raised $905K · modeled $27.9M (est)Westside PetWell, LLC · Pre-Seed Raised $900K · modeled $27.7M (est)Ulster Dialysis Partners, LLC · Pre-Seed Raised $930K · modeled $27.6M (est)DoveMed, Ltd. · Pre-Seed Raised $1.5M · modeled $26.5M (est)New IVS Holdings, LLC (this company) Raised $575K · modeled $17.7M (est)New IVS Holdings, LLC
CompanyStageRaised · realValue · estvs peer med.
Aetas Co LLCPre-Seed$1.0M$30.8M3.80×
Hauppauge SC Holdings, LLCPre-Seed$995K$30.6M3.78×
Gateway IV Lithotripsy, LLCPre-Seed$988K$30.4M3.75×
Endoscopy Center of West Central Ohio, LLCPre-Seed$964K$29.7M3.66×
Dalent LLCPre-Seed$1.9M$29.2M3.61×
FK Investor LLCPre-Seed$940K$29.0M3.57×
Lynx Dx, Inc.Pre-Seed$925K$28.5M3.51×
Center at Arrowhead, LLCPre-Seed$918K$28.3M3.49×
MedTek Valencia eCoin, LLCPre-Seed$905K$27.9M3.44×
Westside PetWell, LLCPre-Seed$900K$27.7M3.42×
Ulster Dialysis Partners, LLCPre-Seed$930K$27.6M3.40×
DoveMed, Ltd.Pre-Seed$1.5M$26.5M3.27×
New IVS Holdings, LLC this companyPre-Seed$575K$17.7M2.18×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$575K2019-10-01$3.2M$17.7M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$575K2019-10-01
    • First recorded raise — entered as Pre-Seed.
    • 15 investors on this round.
Intelligence
Modeled next raise
$920K
Modeled next size est.range $598K$1.5M
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
David Finley2 other2019-10
Gregg Osenkowski2 other2019-10
Registry & provenance

New IVS Holdings, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1790783
SEC CIK
2019
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
In Vitro Sciences, LLCOther Health CareSeries B$31.5M$697.9Mnetwork2 shared operators · same sector
Albion Second Facility LLCOther Health CarePre-Seed$575K$17.7Msame sector · same stage
Ohmm, LlcOther Health CarePre-Seed$575K$17.7Msame sector · same stage
Prana Essentials, Inc.Other Health CarePre-Seed$575K$17.7Msame sector · same stage
Usrc Hickory Hills, LlcOther Health CarePre-Seed$575K$17.7Msame sector · same stage
Usrc West Chicago, LlcOther Health CarePre-Seed$575K$17.7Msame sector · same stage
Westgrove Post Acute AH, L.P.Other Health CarePre-Seed$575K$17.7Msame sector · same stage
Terapio CorpOther Health CarePre-Seed$574K$17.7Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
iVEAcare, Inc.Other Health CareSeries B$108.6M86%
iVinci Partners, LLCOther Health CareSeries A$302.7M86%
Infusion Investors, LLCOther Health CareSeries A$144.4M85%
ImmunSYS, Inc.Other Health CarePre-Seed$8.7M84%
IVitalize, Inc.Other Health CarePre-Seed$15.4M84%
IVXpress, Inc.Other Health CareSeries D+$1.8B84%
New MMI Holdings, Inc.Other Health CareSeries C$1.8B84%
CRES Holdings, Inc.Other Health CareSeries C$67.0M84%
Frequently asked
How much funding has New IVS Holdings, LLC raised?
New IVS Holdings, LLC has raised approximately $575K in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is New IVS Holdings, LLC's estimated valuation?
Provath's modeled valuation for New IVS Holdings, LLC is approximately $17.7M (modeled range $360K–$200.9M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is New IVS Holdings, LLC at?
New IVS Holdings, LLC's latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Tue Oct 01.
What does New IVS Holdings, LLC do and where is it based?
New IVS Holdings, LLC operates in the Other Health Care sector, based in Avon.
Explore related

See where New IVS Holdings, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at New IVS Holdings, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.